Cascade Prodrug Inc
We own a patented platform technolgy that improves the theraputic index of existing cancer drugs so they become safer and more effective.
Operating as a virtual company to leverage capital and global expertise, CPD has several anticancer lead compounds in preclinical development. These lead compounds are prodrug derivatives of blockbuster FDA approved agents to treat cancer. Our business strategy is to modify these FDA approved drugs to create new prodrugs and develop them through Phase I human trials then partner with a major pharmaceutical company.